Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung CancerRui Li, Steven M. Dubinett, Jensen Abascal et al.|Cancer Research|2021Cited by 98
Abstract 2710: Depletion of CXCR2-dependent myeloid-derived suppressor cells (MDSCs) overcomes anti-PD-1 resistance in a murine model of LKB1-deficient non-small cell lung cancer (NSCLC) with high mutational loadRui Li, Steven M. Dubinett, Ramin Salehi‐Rad et al.|Cancer Research|2019Cited by 1
Abstract CT153: Phase I trial of intratumoral administration of autologous <i>CCL21</i> gene-modified dendritic cells in combination with pembrolizumab for advanced NSCLC: Feasibility of repeated IT injectionsBin Liu, Steven M. Dubinett, Fereidoun Abtin et al.|Cancer Research|2024Cited by 1